FDA Extends Comment Period for Proposed Over-the-Counter Human Drugs Labeling Requirements

Summary

The Food and Drug Administration (FDA) is extending the comment period for proposed labeling requirements for over-the-counter (OTC) human drugs until October 6, 1997, in response to requests from manufacturers' associations to allow interested persons adequate time to assess and respond to the proposal.